IRESS LIMITED — Director's Dealing 2012

Sep 13, 2012

14 September 2012

==> picture [114 x 28] intentionally omitted <==

The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

ELECTRONIC LODGEMENT

Dear Sir or Madam

Change in Director’s Interest Notice - Appendix 3Y – Andrew Walsh

Please find attached an Appendix 3Y Notice relating to Deferred Shares and Performance Rights previously granted to Andrew Walsh, Director of the Company.

Yours sincerely,

==> picture [132 x 50] intentionally omitted <==

Peter Ferguson

Company Secretary

IRESS Limited A.B.N. 47 060 313 359

Corporate Office: Level 18, 385 Bourke Street Melbourne Vic Australia Tel: (03) 9018 5800 Fax (03) 9018 5844

Sydney Office:

Suite 4, 14 Martin Place Sydney NSW Australia Tel: (02) 8273 7000 Fax: (02) 8273 7003

www.iress.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IRESS Limited ABN 47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Walsh
Date of last notice	7 May 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct & Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Indirect through Salernes Pty Ltd ATF Walsh Family Trust
Date of change	7 September 2012 – Vesting of Performance Rights 17 May 2012 – Vesting of Deferred shares 7 May 2012 – Granting of Performance Rights and Deferred Shares.

1 * Due to error, vesting of the 2010 Deferred Shares and the 2012 grant of Deferred Shares and Performance Rights were not notified in the Appendix 3Y lodged on 7 May 2012. However, the 2010 Deferred Shares were disclosed in Appendix 3Ys lodged in 2010 and 2011 and the 2012 Deferred Shares and Performance Rights were disclosed in the Company’s Notice of Meeting and approved at the 2012 AGM. Processes have been reviewed to ensure this error does not occur again.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change		Ordinary Shares Direct: 71,950 Indirect 8,000 Unvested Share Grants: Direct: Performance Rights ‘08: Nil Performance Rights ‘09: 100,000 Deferred Shares’09: Nil Performance Rights ‘10: 125,000 Deferred Shares’10: 29,000 Performance Rights issued May 2011: 4 year term measurement commencing May 2011: 150,000 3 year term measurement commencing May 2012: 150,000 Deferred Shares’11: 30,000
Class		Ordinary
Number acquired		Ordinary Shares Direct: 64,000 (Partial vesting of Performance Rights granted in 2009) Direct: 29,000 (Vesting of Deferred Shares granted in 2010) Unvested Share Grants 2 year term Deferred Shares granted 7 May 2012 – 65,000 3 year term Performance Rights granted 7 May 2012 (Measurement commencement 7 May 2013) - 80,000 4 year term Performance Rights granted 7 May 2012 - 80,000
Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Ordinary Shares: As per the Performance Rights plan, the exercise price is$1 per series per participant. There is no exercise price for Deferred Shares. Accordingly, the total consideration (in aggregate) was$1

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change		Ordinary Shares Direct: 164,950 Indirect 8,000 Unvested Share Grants: Direct: Performance Rights ‘08: Nil Performance Rights ‘09: 36,000 (residual of original 100,000) Deferred Shares’09: Nil Performance Rights ‘10: 125,000 Deferred Shares’10: Nil Deferred Shares’11: 30,000 Performance Rights issued May 2011: 4 year term measurement commencing May 2011: - 150,000 3 year term measurement commencing May 2012: - 150,000 Deferred Shares granted 12 – 65,000 Performance Rights issued May 2012: 3 year term Performance Rights granted 7 May 2012 (measurement commencement date 7 May 2013): - 80,000 4 year term Performance Rights granted 7 May 2012: - 80,000
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Vesting of share grants made in prior periods & share grant offer made in May 2012.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Note: If consideration is non-cash, provide details and an estimated valuation Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed All transactions subject to this above traded during a[+] closed period where prior written announcement (vesting of prior clearance was required? year share grants and issue of new share grants) arose from transactions previously approved by both shareholders and board. If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011